Who Buys Irinotecan from India — 495 Importers Behind a $41.1M Market
India's irinotecan import market is served by 495 active buyers who collectively imported $41.1M across 2,905 shipments. FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY) leads with a 19.6% market share, followed by YUSEN LOGISTICS BENELUX BELGIUM and ALLOGA FRANCE. The top 5 buyers together control 40.7% of total import value, reflecting a moderately competitive buyer landscape.
Irinotecan buyer data — 495 importers · $41.1M market · 2,905 shipmentsTransData Nexus · Indian Customs Data
Top Irinotecan Importers — Ranked by Import Value
FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY) is the leading irinotecan importer from India, holding a 19.6% share of the $41.1M market across 2,905 shipments from 495 buyers. The top 5 buyers — FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY), YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), ALLOGA FRANCE (NETHERLANDS), EUGIA PHARMA INC (CANADA), ACCORD HEALTHCARE POLSKA SP. Z.O.O. (POLAND) — collectively control 40.7% of total import value.
Top Irinotecan Buyers & Importers
Ranked by import value · 495 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Irinotecan Buyers & Importers — Ranked by Import Value. 495 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Irinotecan — and from which countries?
Flow of Irinotecan exports from India: each country's share and the named importers behind the numbers
Irinotecan — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 53.0% of global Irinotecan imports — led by Germany (19.7%) with a total trade value of $41.1M across 2,905 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1Germany
Germany emerges as the first largest importing country, achieving a total trade value of $8.1M through 452 shipments. This represents a market share of 19.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Germany has a diverse importer base, with their top importers including:
• FRESENIUS KABI DEUTSCHLAND GMBH - $8.1M (99.6% of country's total business)
Key Insight: Germany demonstrates strong market positioning with an average shipment value of $17.9K, indicating premium pricing strategy compared to the market average of $14.2K.
Germany is a key market for Irinotecan imports, representing 19.7% of total trade value.
Primary Market
Secondary Market
2Poland
Poland emerges as the second largest importing country, achieving a total trade value of $4.4M through 131 shipments. This represents a market share of 10.7% of the total market activity, demonstrating their significant presence in the industry.
The importation of Irinotecan from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like Fresenius Kabi Deutschland GmbH (Germany) and Yusen Logistics Benelux Belgium (Belgium) function as intermediaries, procuring large quantities to supply to healthcare providers. Their purchasing patterns are characterized by bulk orders and consistent procurement schedules to maintain a steady supply chain.
Hospital Groups: Organizations such as Pharmacie Centrale des Hôpitaux (Algeria) represent centralized procurement bodies for hospital networks. They typically engage in large-volume purchases, often through tender processes, to meet the collective needs of associated hospitals.
Contract Manufacturers: Companies like Eugia Pharma Inc (Canada) and Eugia US LLC (United States) specialize in manufacturing pharmaceuticals on behalf of other firms. They import active pharmaceutical ingredients (APIs) like Irinotecan for formulation and packaging, adhering to stringent quality standards. Their procurement is project-based, aligning with production schedules and client demands.
Importing Irinotecan into the top five importing countries involves navigating specific regulatory frameworks:
Germany:
Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).
Import Registration Process: Requires submission of a marketing authorization application, including comprehensive data on quality, safety, and efficacy.
Estimated Timeline: Approximately 7 months, subject to completeness and compliance of the application.
Import Tariff/Duty: As an EU member, Germany applies a standard tariff rate of 0% for pharmaceuticals under HS Code 30049049.
Poland:
Regulatory Authority: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL).
The demand for Irinotecan in importing countries is driven by several factors:
Disease Prevalence: Irinotecan is primarily used in the treatment of colorectal cancer. According to the World Health Organization (WHO), colorectal cancer is among the top three most common cancers worldwide, with increasing incidence rates in many countries.
Government Healthcare Programs: Many countries have national healthcare programs that subsidize cancer treatments, increasing accessibility and demand for drugs like Irinotecan.
Universal Health Coverage Expansion: Efforts to expand universal health coverage in various countries have led to increased procurement of essential medicines, including cancer therapies.
WHO Essential Medicines List Procurement: Irinotecan is included in the WHO Model List of Essential Medicines, guiding countries in prioritizing procurement of critical drugs.
Tender-Based Purchasing: Many healthcare systems utilize tender processes for drug procurement, ensuring competitive pricing and consistent supply of medications like Irinotecan.
Common Questions — Irinotecan Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest irinotecan buyer importing from India?
Based on import volume and value, FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY) leads with $8.1M in imports and a 19.6% market share — the highest of any single irinotecan importer. YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) and ALLOGA FRANCE (NETHERLANDS) are the next largest buyers.
QHow many companies buy irinotecan from India?
There are 495 active irinotecan buyers importing from India, with a combined market of $41.1M across 2,905 shipments to 111 countries. The top 5 buyers hold 40.7% of total import value, while the remaining 490 buyers handle the other 59.3%.
QWhich countries import the most irinotecan from India?
The top importing countries for irinotecan from India are Germany (19.7%), Poland (10.7%), Netherlands (8.3%), Belgium (7.3%), Canada (7.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of irinotecan, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for irinotecan from India?
The average import transaction value for irinotecan from India is $14.2K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
The importation of Irinotecan from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like Fresenius Kabi Deutschland GmbH (Germany) and Yusen Logistics Benelux Belgium (Belgium) function as intermediaries, procuring large quantities to supply to healthcare providers. Their purchasing patterns are characterized by bulk orders and consistent procurement schedules to maintain a steady supply chain.
Hospital Groups: Organizations such as Pharmacie Centrale des Hôpitaux (Algeria) represent centralized procurement bodies for hospital networks. They typically engage in large-volume purchases, often through tender processes, to meet the collective needs of associated hospitals.
Contract Manufacturers: Companies like Eugia Pharma Inc (Canada) and Eugia US LLC (United States) specialize in manufacturing pharmaceuticals on behalf of other firms. They import active pharmaceutical ingredients (APIs) like Irinotecan for formulation and packaging, adhering to stringent quality standards. Their procurement is project-based, aligning with production schedules and client demands.
Importing Irinotecan into the top five importing countries involves navigating specific regulatory frameworks:
Germany:
Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).
Import Registration Process: Requires submission of a marketing authorization application, including comprehensive data on quality, safety, and efficacy.
Estimated Timeline: Approximately 7 months, subject to completeness and compliance of the application.
Import Tariff/Duty: As an EU member, Germany applies a standard tariff rate of 0% for pharmaceuticals under HS Code 30049049.
Poland:
Regulatory Authority: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL).
The demand for Irinotecan in importing countries is driven by several factors:
Disease Prevalence: Irinotecan is primarily used in the treatment of colorectal cancer. According to the World Health Organization (WHO), colorectal cancer is among the top three most common cancers worldwide, with increasing incidence rates in many countries.
Government Healthcare Programs: Many countries have national healthcare programs that subsidize cancer treatments, increasing accessibility and demand for drugs like Irinotecan.
Universal Health Coverage Expansion: Efforts to expand universal health coverage in various countries have led to increased procurement of essential medicines, including cancer therapies.
WHO Essential Medicines List Procurement: Irinotecan is included in the WHO Model List of Essential Medicines, guiding countries in prioritizing procurement of critical drugs.
Tender-Based Purchasing: Many healthcare systems utilize tender processes for drug procurement, ensuring competitive pricing and consistent supply of medications like Irinotecan.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Top Importers: Poland has a diverse importer base, with their top importers including:
• ACCORD HEALTHCARE POLSKA SP. Z.O.O. - $1.5M (33.4% of country's total business)
• ACCORD HEALTHCARE POLSKA SP. Z O.O. - $1.3M (28.6% of country's total business)
• ACCORD HEALTHCARE POLSKA SP Z O O - $563.5K (12.8% of country's total business)
Key Insight: Poland demonstrates strong market positioning with an average shipment value of $33.5K, indicating premium pricing strategy compared to the market average of $14.2K.
Poland is a key market for Irinotecan imports, representing 10.7% of total trade value.
Primary Market
Secondary Market
3Netherlands
Netherlands emerges as the third largest importing country, achieving a total trade value of $3.4M through 116 shipments. This represents a market share of 8.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Netherlands has a diverse importer base, with their top importers including:
• ALLOGA FRANCE - $2.4M (71.1% of country's total business)
• BROCACEF NL : HUB - $744.9K (21.7% of country's total business)
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $29.6K, indicating premium pricing strategy compared to the market average of $14.2K.
Netherlands is a key market for Irinotecan imports, representing 8.3% of total trade value.
Primary Market
Secondary Market
4Belgium
Belgium emerges as the fourth largest importing country, achieving a total trade value of $3.0M through 78 shipments. This represents a market share of 7.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Belgium has a diverse importer base, with their top importers including:
• YUSEN LOGISTICS BENELUX BELGIUM - $2.8M (92.4% of country's total business)
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $38.4K, indicating premium pricing strategy compared to the market average of $14.2K.
Belgium is a key market for Irinotecan imports, representing 7.3% of total trade value.
Primary Market
Secondary Market
5Canada
Canada emerges as the fifth largest importing country, achieving a total trade value of $2.9M through 21 shipments. This represents a market share of 7.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• EUGIA PHARMA INC - $2.0M (68.6% of country's total business)
• ACCORD HEALTHCARE INC - $430.7K (14.8% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $138.8K, indicating premium pricing strategy compared to the market average of $14.2K.
Canada is a key market for Irinotecan imports, representing 7.1% of total trade value.
Primary Market
Secondary Market
Re-exporters: Entities such as Alloga France (Netherlands) and Accord Healthcare Polska Sp. z o.o. (Poland) import pharmaceuticals with the intent to distribute them to other markets. Their purchasing behavior is influenced by global demand fluctuations and regulatory considerations in target markets.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Involves obtaining a marketing authorization, necessitating submission of detailed documentation on the medicinal product.
Estimated Timeline: Typically 7 months, depending on the application's complexity and accuracy.
Import Tariff/Duty: As part of the EU, Poland imposes a 0% tariff on pharmaceuticals classified under HS Code 30049049.
Import Registration Process: Requires a marketing authorization, with submission of extensive data on the product's quality, safety, and efficacy.
Estimated Timeline: Approximately 7 months, contingent upon the thoroughness of the application.
Import Tariff/Duty: As an EU member state, the Netherlands applies a 0% import tariff for pharmaceuticals under HS Code 30049049.
Belgium:
Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).
Import Registration Process: Entails obtaining a marketing authorization, requiring submission of comprehensive product information.
Estimated Timeline: Around 7 months, depending on the application's completeness.
Import Tariff/Duty: Belgium, as part of the EU, imposes a 0% tariff on pharmaceuticals under HS Code 30049049.
Canada:
Regulatory Authority: Health Canada.
Import Registration Process: Requires a Drug Identification Number (DIN) and an Establishment License (EL) for the importer. The foreign manufacturing site must be listed on the importer's EL.
Estimated Timeline: The process can take several months, depending on the completeness of the application and compliance with Good Manufacturing Practices (GMP).
Import Tariff/Duty: Canada generally applies a 0% tariff on pharmaceuticals under HS Code 30049049.
Navigating these regulatory landscapes is essential for successful market entry and sustained operations in these countries.
TransData Nexus Research · Government and regulatory sourcesMar 2026
With 495 buyers across 111 countries, the global reach and consistent demand for Irinotecan underscore its significance in cancer treatment protocols worldwide.
TransData Nexus Research · Government and regulatory sourcesMar 2026
$110.05 per unit
Re-exporters: Entities such as Alloga France (Netherlands) and Accord Healthcare Polska Sp. z o.o. (Poland) import pharmaceuticals with the intent to distribute them to other markets. Their purchasing behavior is influenced by global demand fluctuations and regulatory considerations in target markets.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Involves obtaining a marketing authorization, necessitating submission of detailed documentation on the medicinal product.
Estimated Timeline: Typically 7 months, depending on the application's complexity and accuracy.
Import Tariff/Duty: As part of the EU, Poland imposes a 0% tariff on pharmaceuticals classified under HS Code 30049049.
Import Registration Process: Requires a marketing authorization, with submission of extensive data on the product's quality, safety, and efficacy.
Estimated Timeline: Approximately 7 months, contingent upon the thoroughness of the application.
Import Tariff/Duty: As an EU member state, the Netherlands applies a 0% import tariff for pharmaceuticals under HS Code 30049049.
Belgium:
Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).
Import Registration Process: Entails obtaining a marketing authorization, requiring submission of comprehensive product information.
Estimated Timeline: Around 7 months, depending on the application's completeness.
Import Tariff/Duty: Belgium, as part of the EU, imposes a 0% tariff on pharmaceuticals under HS Code 30049049.
Canada:
Regulatory Authority: Health Canada.
Import Registration Process: Requires a Drug Identification Number (DIN) and an Establishment License (EL) for the importer. The foreign manufacturing site must be listed on the importer's EL.
Estimated Timeline: The process can take several months, depending on the completeness of the application and compliance with Good Manufacturing Practices (GMP).
Import Tariff/Duty: Canada generally applies a 0% tariff on pharmaceuticals under HS Code 30049049.
Navigating these regulatory landscapes is essential for successful market entry and sustained operations in these countries.
TransData Nexus Research · Government and regulatory sourcesMar 2026
With 495 buyers across 111 countries, the global reach and consistent demand for Irinotecan underscore its significance in cancer treatment protocols worldwide.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 495 global importers of Irinotecan identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 2,905 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 111 destination countries with market share per buyer calculated from capped values.
